Literature DB >> 19427854

Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.

Romain Cartoni1, Jean-Claude Martinou.   

Abstract

Charcot-Marie-Tooth disease (CMT) is the most common form of hereditary peripheral neuropathy. The main axonal form of CMT, CMT2A, preferentially affects peripheral neurons with the longest neurites. CMT2A has been recently linked to mutations in the mitofusin 2 (Mfn2) gene. Mfn2 participates in mitochondrial fusion a process that together with mitochondrial fission, contributes to mitochondrial morphology. Many hypotheses have been postulated to understand how mutations in Mfn2 lead to CMT2A. In this review, we will describe the physiological role of Mfn2, the pathophysiology of CMT2A and current hypotheses about the deleterious role of mutant Mfn2 in neuronal function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427854     DOI: 10.1016/j.expneurol.2009.05.003

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  54 in total

Review 1.  Mitochondrial fission and fusion and their roles in the heart.

Authors:  Lesley A Kane; Richard J Youle
Journal:  J Mol Med (Berl)       Date:  2010-09-14       Impact factor: 4.599

2.  Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy.

Authors:  Andrea M Vincent; James L Edwards; Lisa L McLean; Yu Hong; Federica Cerri; Ignazio Lopez; Angelo Quattrini; Eva L Feldman
Journal:  Acta Neuropathol       Date:  2010-05-15       Impact factor: 17.088

3.  Diabetes regulates mitochondrial biogenesis and fission in mouse neurons.

Authors:  J L Edwards; A Quattrini; S I Lentz; C Figueroa-Romero; F Cerri; C Backus; Y Hong; E L Feldman
Journal:  Diabetologia       Date:  2009-10-22       Impact factor: 10.122

Review 4.  Mitochondrial Proteolysis and Metabolic Control.

Authors:  Sofia Ahola; Thomas Langer; Thomas MacVicar
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

5.  Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model.

Authors:  Yueqin Zhou; Sharon Carmona; A K M G Muhammad; Shaughn Bell; Jesse Landeros; Michael Vazquez; Ritchie Ho; Antonietta Franco; Bin Lu; Gerald W Dorn; Shaomei Wang; Cathleen M Lutz; Robert H Baloh
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

Review 6.  Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel.

Authors:  Andrew P Wojtovich; C Owen Smith; Cole M Haynes; Keith W Nehrke; Paul S Brookes
Journal:  Biochim Biophys Acta       Date:  2013-01-02

7.  S-nitrosylation of Cdk5: potential implications in amyloid-β-related neurotoxicity in Alzheimer disease.

Authors:  Jing Qu; Tomohiro Nakamura; Emily A Holland; Scott R McKercher; Stuart A Lipton
Journal:  Prion       Date:  2012-08-09       Impact factor: 3.931

8.  Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria.

Authors:  Christopher J Klein; Grace W Kimmel; Sean J Pittock; JaNean E Engelstad; Julie M Cunningham; Yanhong Wu; Peter J Dyck
Journal:  Arch Neurol       Date:  2011-10

Review 9.  Mitochondrial dynamic changes in health and genetic diseases.

Authors:  Le Chen; Allison J Winger; Anne A Knowlton
Journal:  Mol Biol Rep       Date:  2014-11       Impact factor: 2.316

Review 10.  Control of mitochondrial integrity in ageing and disease.

Authors:  Radek Szklarczyk; Marco Nooteboom; Heinz D Osiewacz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-07-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.